Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin 90 mg/m2 iv|DRUG: Cyclophosphamide 600 mg/m2 iv|DRUG: Docetaxel 100 mg/m2 iv OR paclitaxel 80 mg/m2 iv|DRUG: Trastuzumab 8 mg/kg iv saturation, then 6 mg/kg iv (HER2 positive patients only)|DRUG: Pertuzumab 840 mg iv saturation, then 420 mg iv (selected HER2 positive patients only)|DIETARY_SUPPLEMENT: Tocotrienol 300 mg x 3 daily
Sponsor: Vejle Hospital